Magnesium Sulfate as an Adjunct to General Anesthesia: Clinical Perspective
Magnesium sulfate can be used as an effective adjunct during general anesthesia to reduce anesthetic, opioid, and neuromuscular blocker requirements, with a recommended dosing regimen of 30-50 mg/kg IV bolus followed by 10 mg/kg/h continuous infusion. 1
Pharmacologic Effects During General Anesthesia
Magnesium sulfate exerts multiple beneficial effects when used as an adjunct to general anesthesia:
Anesthetic-Sparing Effects
Magnesium significantly reduces requirements for primary anesthetic agents. A single IV injection of 30-50 mg/kg followed by continuous infusion at 10 mg/kg/h reduces propofol, opioid, and neuromuscular blocker consumption during total intravenous anesthesia (TIVA). 1 Research demonstrates that this regimen can reduce remifentanil consumption from 0.14 to 0.09 μg/kg/min and mivacurium requirements by approximately 20%, while propofol consumption may remain unchanged or increase slightly depending on the clinical scenario 2, 3, 4.
Analgesic Properties
Magnesium provides meaningful postoperative analgesia through NMDA receptor antagonism. A 2026 meta-analysis of 22 randomized trials involving 1750 patients found that IV magnesium reduced early postoperative pain (0-6 hours) by 0.90 points on a 0-10 scale and pain at 24 hours by 0.59 points, with moderate certainty of evidence for the 24-hour endpoint 5. Postoperative opioid consumption decreased by approximately 6.3 mg morphine equivalents, and time to first rescue analgesia was prolonged by 85 minutes 5.
Hemodynamic Stabilization
For hypertensive patients, 30 mg/kg is the optimal dose to control blood pressure during intubation without causing hypotension. Higher doses (40-50 mg/kg) significantly increase the risk of hypotension requiring intervention—30% of patients at 40 mg/kg and 50% at 50 mg/kg required vasopressor support 6. This dose-dependent effect is critical for clinical decision-making.
Additional Benefits
Magnesium at 30 mg/kg effectively suppresses sufentanil-induced cough during induction (reducing incidence from 47% to 16%) 7 and may reduce propofol injection pain when lidocaine is used concurrently 1.
Recommended Dosing Protocol
Standard regimen for general anesthesia adjunct:
- Loading dose: 30-50 mg/kg IV over 10-15 minutes before or during induction
- Maintenance infusion: 10 mg/kg/h until end of surgery
- Duration of effect: Single bolus lasts approximately 2 hours; continuous infusion needed for longer cases 3
For specific indications:
- Intubation response in hypertensive patients: 30 mg/kg bolus (avoid higher doses due to hypotension risk) 6
- Cough suppression: 30 mg/kg bolus 1 minute before opioid administration 7
- Postoperative analgesia optimization: Full loading dose plus maintenance infusion 5
Critical Safety Considerations and Contraindications
Monitoring Requirements
Clinical monitoring is mandatory and takes precedence over laboratory values. 8
Essential monitoring parameters:
- Patellar reflex (knee jerk): Must be present before each repeated dose; absence indicates toxicity
- Respiratory rate: Maintain ≥16 breaths/min; respiratory depression occurs at toxic levels
- Urine output: Maintain ≥100 mL per 4 hours (magnesium is renally excreted)
- Serum magnesium levels: Therapeutic range 3-6 mg/100 mL (2.5-5 mEq/L); reflexes diminish >4 mEq/L; respiratory paralysis risk at 10 mEq/L 8
Absolute Contraindications
- Renal impairment: Magnesium is eliminated solely by kidneys; use only with extreme caution and reduced doses if creatinine clearance is compromised 8
- Myasthenia gravis or neuromuscular disease: Magnesium potentiates neuromuscular blockade unpredictably 9
Drug Interactions Requiring Dose Adjustment
When barbiturates, narcotics, hypnotics, or systemic anesthetics are co-administered with magnesium, reduce their dosage due to additive CNS depressant effects. 8 This is the mechanism underlying magnesium's anesthetic-sparing properties but requires active titration.
Neuromuscular blocking agents: Excessive neuromuscular block occurs when magnesium is combined with rocuronium, vecuronium, or mivacurium. Reduce neuromuscular blocker doses by 20-30% and monitor train-of-four closely 9, 8, 2.
Cardiac glycosides: Administer with extreme caution in digitalized patients; serious cardiac conduction changes and heart block may occur if calcium is required to treat magnesium toxicity 8.
Pregnancy-Specific Warning
Continuous maternal administration beyond 5-7 days causes fetal abnormalities including hypocalcemia, skeletal demineralization, and osteopenia. 8 For perioperative use in pregnant patients, limit exposure to the surgical period only.
What NOT to Do: Evidence-Based Restrictions
Neuraxial Administration
Do not administer magnesium sulfate via epidural or intrathecal routes. The 2026 PROSPECT guidelines explicitly state that magnesium as an adjuvant for thoracic epidural analgesia is not recommended due to risk of adverse effects, including potential neurotoxicity 10. The American Society of Regional Anesthesia and Pain Medicine does not recommend neuraxial magnesium 10.
Systemic Use in Thoracic Surgery
Intravenous magnesium sulfate is not recommended for postoperative analgesia after open thoracotomy due to lack of evidence. 10 The 2026 PROSPECT guidelines found insufficient data to support its use in this specific population, despite its benefits in other surgical contexts.
Dexmedetomidine Combination
When magnesium is used as an epidural or regional adjuvant alongside dexmedetomidine, the unfavorable benefit-to-risk profile (increased adverse effects without proportional analgesic benefit) makes this combination inadvisable 10.
Practical Implementation Algorithm
Step 1: Patient Selection
- Confirm normal renal function (creatinine clearance >60 mL/min)
- Exclude neuromuscular disease
- Verify no heart block or digitalis therapy
Step 2: Dosing Decision
- Normotensive patients: 30-50 mg/kg loading dose
- Hypertensive patients: 30 mg/kg loading dose (do not exceed to avoid hypotension)
- All patients: 10 mg/kg/h maintenance if surgery >2 hours
Step 3: Anesthetic Adjustment
- Reduce opioid infusion rates by 20-30% from baseline
- Reduce neuromuscular blocker doses by 20-30%
- Titrate propofol to bispectral index or clinical effect (may require same or slightly higher doses)
Step 4: Intraoperative Monitoring
- Check patellar reflex every 30-60 minutes if repeated dosing
- Monitor respiratory rate continuously
- Maintain urine output ≥25 mL/h
Step 5: Toxicity Management
- Have calcium gluconate or calcium chloride immediately available (10 mL of 10% solution IV over 3 minutes reverses magnesium toxicity) 8
- If reflexes absent or respiratory rate <12/min: stop magnesium, administer calcium, support ventilation
Evidence Quality and Limitations
The certainty of evidence varies by outcome. The 2026 meta-analysis rated evidence as moderate for pain at 24 hours but very low to low for other endpoints due to substantial heterogeneity (I² values 66-96%) 5. Most studies used different surgical populations, magnesium doses, and co-analgesic regimens, limiting generalizability.
The most robust evidence supports:
- Opioid-sparing effects during maintenance of anesthesia (multiple RCTs, consistent findings) 2, 3, 4
- Hemodynamic stabilization at 30 mg/kg in hypertensive patients (well-designed dose-finding study) 6
- Postoperative analgesia at 24 hours (moderate certainty, large meta-analysis) 5
Weaker evidence exists for:
- Propofol-sparing effects (conflicting results across studies)
- Pain reduction at 12 hours postoperatively (no significant effect in meta-analysis)
- Long-term safety in repeated perioperative use
Common Pitfalls to Avoid
Dosing too high in hypertensive patients: Doses >30 mg/kg cause hypotension requiring intervention in 30-50% of cases 6
Forgetting renal function assessment: Magnesium accumulates rapidly in renal impairment, causing toxicity even at standard doses 8
Inadequate neuromuscular blocker dose reduction: Failure to reduce rocuronium/vecuronium by 20-30% leads to prolonged paralysis 9, 2
Lack of calcium availability: Magnesium toxicity can progress rapidly; calcium must be drawn up and ready before starting infusion 8
Using neuraxial routes: Despite historical use, current guidelines explicitly advise against epidural/intrathecal magnesium due to neurotoxicity concerns 10, 11
Assuming universal benefit: Magnesium is not recommended for all surgical populations (e.g., thoracotomy patients) and should be used selectively based on available evidence 10